HCW Biologics Inc.
HCWB | NASDAQ
$1.91
+$0.04 (+2.14%)
At close: Sep 21, 2026, 4:00 PM ET
$1.93
+$0.02 (+1.05%)
Pre-market:
Sep 22, 2026, 6:40 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -5.58M | -2.29M | -7.96M | -12.05M | -11.4M | -24.75M | -30.02M | -37.33M | -38.37M | -27.39M | -24.99M | -19.73M | -18.71M | -17.91M | -14.9M | -12.66M | -12.84M | -12.08M | -12.86M | -7.63M | -6.24M | -6.27M |
Depreciation & Amortization | 599.99K | 764.81K | 1.04M | 1.57M | 1.52M | 1.36M | 1.18M | 776.43K | 925.44K | 1.08M | 1.14M | 1.12M | 1.01M | 873.92K | 717.85K | 552.28K | 510.4K | 515.7K | 531.72K | 599.82K | 603.58K | 606.81K |
Stock-Based Compensation | 20.42K | 297.51K | 563.13K | 846.02K | 1.08M | 1.04M | 1.01M | 978.21K | 965.63K | 989.23K | 1M | 1.03M | 1.11M | 1.12M | 1.12M | 834K | 533.34K | 272.23K | 11.88K | 11.88K | 10.22K | n/a |
Other Working Capital | 488.95K | 752K | 141.99K | 165.48K | 132.97K | 271.09K | 775.08K | 1.37M | 963.24K | -5M | -5.14M | -5.15M | -4.92M | 1.09M | 2.35M | 1.15M | -422.77K | -1.28M | -2.8M | -4.32M | -2.9M | -2.46M |
Other Non-Cash Items | -6.6M | -8.57M | -4.26M | -375.9K | -1.73M | 150K | -418 | 5.25M | 5.21M | 5.1M | 4.98M | -331.67K | -245.57K | -109.16K | 188.46K | 710.08K | 665.24K | 640.39K | -112.25K | -545.44K | -545.44K | -545.44K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -575.09K | -1.65M | -2.78M | -2.86M | -2.03M | 8.07M | 13.6M | 15.04M | 13.32M | -2.25M | -4.64M | -4.5M | -2.3M | 3.6M | 2.49M | 585.68K | -1.65M | -430.72K | 1.46M | -3.57M | -2.59M | -3.73M |
Operating Cash Flow | -12.14M | -11.45M | -13.39M | -12.87M | -12.56M | -14.14M | -14.23M | -15.29M | -17.95M | -22.48M | -22.51M | -22.41M | -19.13M | -12.43M | -10.39M | -9.97M | -12.78M | -11.08M | -10.98M | -11.14M | -8.77M | -9.94M |
Capital Expenditures | -2 | -3 | -3 | -113.41K | -150.48K | -131.91K | -261.62K | -3.86M | -4.46M | -6.03M | -6.2M | -2.56M | -12.1M | -10.55M | -10.28M | -10.23M | -60.45K | -47.54K | -47.26K | -63.8K | -164.89K | -164.89K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.05K | -4.05K | -4.05K | -4.05K | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10M | 10M | 10M | 10M | 16.98M | 16.98M | 24.98M | 24.98M | 8M | 8M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -34.97M | -34.97M | -34.97M | -34.97M | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | -113.41K | -150.48K | -131.91K | -261.62K | -3.86M | 5.54M | 3.97M | 3.8M | 7.44M | 4.89M | 6.43M | 14.71M | 14.75M | -27.03M | -27.02M | -35.02M | -35.03M | -164.89K | -109.1K |
Debt Repayment | -323.54K | -204.47K | 22.38K | 399.21K | 3.23M | 5.03M | 6.79M | 6.41M | 3.6M | 1.68M | -38.27K | -8.98K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.16M | 3.52M | 3.5M | 6.14M | 6.14M | 2.3M | 2.32M | n/a | n/a | n/a | n/a | -45.68K | 6.26M | 6.26M | 6.26M | 6.3M | -5.84M | -6.66M | -6.76M | -6.2M | 5.81M | 6.63M |
Financial Cash Flow | 10.44M | 11.57M | 10.67M | 13.08M | 13.99M | 11.29M | 15.57M | 8.93M | 6.12M | 4.21M | -14.53K | -39.13K | 6.27M | 6.27M | 6.27M | 6.32M | 50.18M | 49.36M | 49.27M | 54.81M | 10.81M | 11.63M |
Net Cash Flow | -1.7M | 121.27K | -2.72M | 98.69K | 1.28M | -2.98M | 1.08M | -10.22M | -6.29M | -14.31M | -18.73M | -15M | -7.97M | 272.59K | 10.6M | 11.1M | 10.37M | 11.26M | 3.27M | 8.64M | 1.88M | 1.58M |
Free Cash Flow | -12.14M | -11.45M | -13.39M | -12.98M | -12.71M | -14.27M | -14.49M | -19.15M | -22.41M | -28.51M | -28.72M | -24.96M | -31.23M | -22.98M | -20.66M | -20.2M | -12.84M | -11.13M | -11.02M | -11.2M | -8.93M | -10.1M |
Adj. Free Cash Flow | -12.16M | -11.75M | -13.95M | -13.83M | -13.79M | -15.31M | -15.5M | -20.13M | -23.37M | -29.5M | -29.72M | -25.99M | -32.34M | -24.1M | -21.78M | -21.03M | -13.37M | -11.4M | -11.03M | -11.21M | -8.94M | -10.1M |
Maintenance CapEx | -10 | -3 | -3 | -113.41K | -150.48K | -131.91K | -131.91K | -3.73M | -4.33M | -5.46M | -5.76M | -2.04M | -8.98M | -7.87M | -7.57M | -7.59M | -23.98K | -23.98K | -47.26K | -63.8K | -164.89K | -164.89K |
Growth CapEx | 8 | n/a | n/a | n/a | n/a | n/a | -129.71K | -129.71K | -129.71K | -574.4K | -444.69K | -513.37K | -3.11M | -2.68M | -2.7M | -2.63M | -36.46K | -23.55K | n/a | n/a | n/a | n/a |
Owner Earnings | -12.14M | -11.45M | -13.39M | -12.98M | -12.71M | -14.27M | -14.36M | -19.02M | -22.28M | -27.94M | -28.27M | -24.45M | -28.12M | -20.3M | -17.96M | -17.57M | -12.8M | -11.1M | -11.02M | -11.2M | -8.93M | -10.1M |
Add to Watchlist
Select watchlists to add or remove HCWB